News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Malavika Prabhu, MD

Advertisement

Articles by Malavika Prabhu, MD

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

ByThe Society for Maternal-Fetal Medicine (SMFM),Malavika Prabhu, MD,Jeffrey A. Kuller, MD,Joseph Biggio, MD, MS
April 5th 2022

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary OB/GYN

    1

    FDA document review details evidence-based oversight of mifepristone

    2

    Postpartum BP control tied to brain volume after hypertension

    3

    Emily Lam highlights rising gestational diabetes rates in US populations

    4

    IV iron dextran found cost-effective as first-line treatment for IDA in heavy menstrual bleeding

    5

    Maternal influenza and Tdap vaccination linked to fewer infant hospital and emergency visits

    • Advertise
    • Contact Us
    • Job Board
    • Terms of Use
    • Privacy Policy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us